David Wyld

10PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPacific Peoples nursingPacific Peoples theory of change models for healthCross-sectional analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 27, 2026
A Multicenter Phase II Randomized Controlled Trial Comparing 177Lu-Dotatate/Capecitabine Combination Treatment with 177Lu-Dotatate Monotherapy in Patients with Neuroendocrine Tumors.

Morticia N Becx, Johannes Hofland, Eric P Krenning

|May 27, 2025
Peptide receptor radionuclide therapy in malignant insulinoma.

David A Pattison, Grace Kong, Timothy Akhurst

|Aug 27, 2024
Implementation of Patient-Reported Outcomes in a Medical Oncology Setting (the iPROMOS Study): Type II Hybrid Implementation Study.

Natasha Anne Roberts, Anita Pelecanos, Kimberly Alexander

|Nov 25, 2023
The Unmet Needs of Pancreatic Cancer Carers Are Associated with Anxiety and Depression in Patients and Carers.

Thi N T Huynh, Gunter Hartel, Monika Janda

|Sep 15, 2023
The unmet information needs, quality of life, and care experiences of patients with neuroendocrine tumours (NETs) at follow-up: 6 months from diagnosis.

Lisa Guccione, Karla Gough, Allison Drosdowsky

|Feb 20, 2020
The Economic Impact on Australian Patients with Neuroendocrine Tumours.

Louisa G Gordon, Thomas M Elliott, Kate Wakelin

Pageof 2

Frequent Collaborators

3 joint publications

Michael Michael

3 joint publications

Monika Janda

3 joint publications

Nick Pavlakis

3 joint publications

Kimberly Alexander